Oppenheimer Asset Management Inc. Sells 17,913 Shares of CME Group Inc. (NASDAQ:CME)

Oppenheimer Asset Management Inc. lessened its holdings in shares of CME Group Inc. (NASDAQ:CME) by 55.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,618 shares of the financial services provider’s stock after selling 17,913 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in CME Group were worth $3,225,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. Capital International Investors grew its holdings in shares of CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after buying an additional 3,069,806 shares during the last quarter. PineStone Asset Management Inc. boosted its stake in CME Group by 137.6% during the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after purchasing an additional 1,309,097 shares during the last quarter. Assenagon Asset Management S.A. boosted its stake in CME Group by 577.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock valued at $126,872,000 after purchasing an additional 550,133 shares during the last quarter. Ameriprise Financial Inc. increased its holdings in CME Group by 11.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after purchasing an additional 537,758 shares in the last quarter. Finally, International Assets Investment Management LLC raised its stake in shares of CME Group by 21,465.5% in the third quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider’s stock worth $1,072,070,000 after purchasing an additional 483,618 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $235.00 target price on shares of CME Group in a research report on Thursday, October 24th. Keefe, Bruyette & Woods lifted their price objective on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a report on Monday, November 11th. Piper Sandler lifted their target price on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research report on Monday, October 28th. Finally, Bank of America increased their price target on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $224.47.

CME Group Stock Up 0.8 %

CME stock opened at $225.28 on Friday. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.36. The stock has a fifty day moving average of $222.52 and a 200-day moving average of $210.26. The company has a market capitalization of $81.12 billion, a price-to-earnings ratio of 23.69, a PEG ratio of 5.26 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company’s revenue was up 18.4% on a year-over-year basis. During the same quarter last year, the company earned $2.25 earnings per share. As a group, equities research analysts predict that CME Group Inc. will post 10.23 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be given a dividend of $1.15 per share. The ex-dividend date is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.04%. CME Group’s dividend payout ratio is currently 48.37%.

Insiders Place Their Bets

In related news, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the transaction, the director now owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. The trade was a 1.57 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 12.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,621 shares of company stock worth $3,441,063 over the last 90 days. Corporate insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.